Page last updated: 2024-12-06
fluoroacetaldehyde
Description
fluoroacetaldehyde : An aldehyde that is acetaldehyde in which one of the hydrogens of the methyl group is replaced by fluorine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
PubMed CID | 73766 |
CHEBI ID | 14272 |
MeSH ID | M0204295 |
Synonyms (13)
Synonym |
unii-mf7qxp9sqb |
mf7qxp9sqb , |
4-01-00-03132 (beilstein handbook reference) |
brn 1734626 |
acetaldehyde, fluoro- |
fluoroacetaldehyde |
1544-46-3 |
CHEBI:14272 |
2-fluoroacetaldehyde |
DTXSID80165621 |
Q18389998 |
2-fluoroethanal |
.alpha.-fluoroacetaldehyde |
Roles (1)
Role | Description |
cardiotoxic agent | A role played by a chemical compound exihibiting itself through the ability to induce damage to the heart and cardiomyocytes. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (2)
Class | Description |
organofluorine compound | An organofluorine compound is a compound containing at least one carbon-fluorine bond. |
aldehyde | A compound RC(=O)H, in which a carbonyl group is bonded to one hydrogen atom and to one R group. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 22.14
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 22.14 (24.57) | Research Supply Index | 1.95 (2.92) | Research Growth Index | 4.78 (4.65) | Search Engine Demand Index | 18.60 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 1 (16.67%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (83.33%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |